[XENE] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
05-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 11.35%
YoY- 38.32%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 132 8,124 6,554 3,500 0 264 413 -17.30%
PBT -37,737 -15,650 -9,058 -8,866 -14,383 -7,742 -7,714 30.27%
Tax -587 -205 -203 5 678 -902 383 -
NP -37,150 -15,445 -8,855 -8,871 -14,383 -7,742 -7,714 29.93%
Tax Rate - - - - - - - -
Total Cost 37,282 23,569 15,409 12,371 14,383 8,006 8,127 28.88%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -28,143.94 -190.12 -135.11 -253.46 0.00 -2,932.58 -1,867.80 57.12%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.59 -0.37 -0.25 -0.34 -0.71 -0.43 -0.51 2.45%
EPS Diluted -0.57 -0.37 -0.25 -0.34 -0.71 -0.43 -0.51 1.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.